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In case of low dose exposure to a substance, its concentration in cells is likely to be stochastic. 
Assessing the consequences of this stochasticity in toxicological risk assessment requires the 
coupling of macroscopic dynamics models describing whole body kinetics with microscopic 
tools designed to simulate stochasticity. In this paper, we propose an approach to approximate 
stochastic cell concentration of butadiene in the cells of diverse organs. We adapted the 
dynamics equations of a physiologically-based pharmacokinetic (PBPK) model and used a 
stochastic simulator for the system of equations we derived. We then coupled kinetics 
simulations with a deterministic hockey stick model of carcinogenicity. Stochasticity induced 
substantial modifications relative to dose-response curve, compared to the deterministic 
situation. In particular, there was non-linearity in the response and stochastic apparent 
threshold was lower than the deterministic one. The approach we developed could easily be 
extended to other biological studies to assess the influence at macroscopic scale of 
stochasticity for compounds dynamics at cell level.  
 




The dynamics of chemical species at the level of the cell are rather discrete and stochastic 
than continuous and deterministic, in so far as they are determined by the action of only a few 
molecules (Rao and Arkin, 2003). Stochastic resonance in biology is a well known 
phenomenon, able to enhance detection and improve the transmission efficiency of weak 
information in nonlinear systems (Hänggi, 2002). In particular, it explains why deterministic 
threshold can be exceeded, with a rate in relation to the intensity of the signal, even if the 
mean value of this signal throughout time is below the threshold. The concepts apply to 
toxicology: For low exposures to a chemical, stochasticity is likely to play a role in the 
occurrence of toxic effects at the cell level, even if the mean cellular concentration is below 
some deterministic threshold, inferred for instance, through mechanistic considerations 
(Lovell, 2000). Studying stochasticity in toxicant cellular concentration is particularly 
relevant for carcinogenesis which might be induced at very low doses of exposure.  In this 
paper, we present a modelling framework to simulate stochastic concentrations at cell level 
and to derive consequences for cancer risk assessment. Simulations are performed based on 
actual exposure levels and a physiologically-based toxicokinetic model for butadiene. 
1,3-Butadiene is a highly volatile four-carbon chemical mostly made from the processing of 
petroleum. It can be detected in urban air pollution, cigarette smoke and gasoline vapors. 
Butadiene is an established carcinogen, as a DNA-reactive chemical leading to production of 
DNA adducts in rodents in liver, lung and tissue (Preston, 2007). It is hypothesized that 
butadiene carcinogenicity is a consequence of the genotoxicity of its metabolites (Albertini et 






Physiologically based toxicokinetic (PBPK) models propose a realistic even if simplified 
description of the mechanisms of absorption, distribution, metabolism and elimination of 
chemicals in the body. In these models, the body is subdivided into various compartments 
representing specific organs or homogeneous groups of tissues linked and irrigated by blood 
vessels. Compartments are characterized by a set of parameters of physiological relevance 
(e.g., volume or blood perfusion rate) which play a crucial role in explaining the behavior of 
chemical substances in the body, and represent invariants across substances. A three-
compartment physiologically based pharmacokinetics (PBPK) model has been proposed to 
describe the distribution of butadiene and the production of its first metabolite following 
oxidation, 1,2-epoxy-3-butene (Brochot and Bois, 2005). We use here an extension of this 
model with 23 compartments.  The model parameters (organ volumes etc.) correspond to 
those of an adult man.  
These macroscopic models can describe the distribution of chemicals in the different organs 
but are unable to capture the stochasticity at cell level. In contrast, a recent discipline, systems 
biology, aims at studying the dynamics of the components of a cell, and tools to study the 
influence of stochasticity at cell level have being developed. The main objective of this paper 
is to develop a methodology for coupling microscopic and macroscopic dynamics models to 
assess the consequences at organ level of stochastic chemical concentration and effects at cell 
level. Coupling PBPK models and systems biology is a step forward to develop integrated 
approaches able to relate information obtained at cell level, like for instance “omics” data, and 







2. MATERIALS AND METHODS 
2.1. PBPK model for butadiene 
Our PBPK model contains 23 compartments (See Figure 1). Compartments are mainly 
connected by blood circulation, by air exchange at the lung level, excretion to urine and feces, 
and metabolism. Concentrations C, in µg/L, are obtained at any time by dividing the quantity 
of butadiene, Q (in µg) by the compartment volume (supposed constant in time). Volumes are 
in L, time in min, flows and rates in L/min. Q and C depend on time but we omit the time 
argument when possible for simpler notation.  A list of parameters and their values can be 
found in Tables I-IV. We assume that butadiene is only eliminated through metabolisation or 
exhalation, and that intake only occurs through inhalation. 
For adipose tissue, adrenals, bone marrow, brain, breast, heart, kidneys, muscles, other organs 
and tissues, pancreas, skin, spleen, testes and thyroid, the differential equation giving the rate 



















where Fi are blood flows (values given in Table 2), and Pi are tissue over blood partition 
coefficients. These partition coefficients were calculated by multiplying the partition 
coefficients for fat (Table III) by fat content of each organ  (Table IV). Indeed, for highly 
lipohilic organic chemicals, Pi values can be approximated by the ratio of lipids in adipose 






























where Fpul designates the pulmonary ventilation rate (9 L/min for an average human) and Falv 
the alveolar ventilation rate (6 L/min) (ICRP, 2002). 






































where Ftotal designates the sum of the F values for the following organs or tissues: adipose 
tissue, adrenals, bone marrow, brain, breast, heart, kidneys, liver, muscles, other organs and 
tissues, skin, testes and thyroid. 
For the liver, blood comes from the arterial pool, spleen, pancreas, stomach and gut, and there 





























































































where i designates the adipose tissue, adrenals, bone marrow, brain, breast, heart, kidneys, 
liver, muscles, other organs and tissues, skin, testes and thyroid. 
















For simplicity, the possibility of EB molecules to come back to the liver through blood 
circulation has been neglected, assuming susbtantial elimination through secondary 
metabolism and exhalation. To obtain more relevance, incorporating EB kinetics may be 
proposed later, based on the PBPK model for butadiene and major metabolites proposed by 
Brochot et al. (2007).  
 
2.2. Exposure and epidemiological data 
We used data from Higashino et al. (2007) on human exposures to 1,3-butadiene in Japan. 
The average concentration in the general environment is 0.25 µg/m3, with a background 
concentration 0.06 µg/m3 in unpolluted areas. Exposure concentrations above 0.8 µg/m3 are 
only found in vicinity of industrial activities. Lifetime excess cancer risk level is estimated at 
10-5 for an exposure concentration of 1.7 µg/m3 (Higashino et al., 2007). In Japan, 0.03% of 
the total population (that is 36 000 persons) are exposed to concentrations exceeding this 
value. With a molar mass of 54.09 g/mol for butadiene, 1.7 µg/m3 corresponds to 18.7 1012 
molecules/L.  
 
2.3. Simulation Software used  
We used the Systems Biology Workbench (SBW) (Sauro et al., 2003), version 2.0.39. We 
implemented our PBPK model in Jdesigner. The model was then converted to an SBML file 
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and input in the Dizzy 1.11.4 software (Ramsey et al., 2005), which is able to perform 
stochastic simulations of chemical kinetics. We used the Gillespie stochastic algorithm 
(Gillespie, 1977) for stochastic simulations. It is an algorithm for modeling the kinetics of a 
set of coupled chemical reactions, taking into account stochastic effects from low copy 
numbers of the chemical species. With the same differential equation, the deterministic 
approach regards the time evolution as continuous, whereas the stochastic approach regards 
the time evolution as a kind of random-walk process. In Gillespie's approach, chemical 
reaction kinetics are modelled as a Markov process in which reactions occur at specific times 
separated by Poisson-distributed intervals. The mean interval is recomputed each reaction 
time. At each reaction time, a specific chemical reaction occurs, randomly selected from the 
set of all possible reactions with a probability given by the individual reaction rates. 
 
2.4. Stochastic simulations at steady state 
Exact stochastic simulators track the actual number of molecules involved in a set of reaction 
in a given portion of space. It is impossible for them to handle as many molecules as can be 
found in an entire organ. We first computed the steady state concentration values in each 
organ using the deterministic (ordinary differential equation) simulator of the SBW, with 
continuous inhalation exposure concentrations of 0.25 and 1.7 mg/m3 of BD. Initial condition 
for the number of molecules in a cell was set to the deterministic value from the PBPK model. 
We consider that a human has typically about 1014 cells. In our PBPK model, the total volume 
of a man is 75 L, which results in a mean density of 1.37 1012 cells/L. 
 
Except for liver, the uptake of butadiene is performed from the arterial blood, in which 
butadiene concentration was set at steady state deterministic value from PBPK model. The 
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This equation cannot be computed directly in the softwares we use because of rounding errors 































 (10)  
where ℵ is the Avogadro’s number, Mbutadiene is the molar weight of butadiene and Ncell the 
number of molecules in the cell. This equation can be studied with Jdesigner and Dizzy with a 
fixed Cart  value. Equation (4) was reformulated in a similar way.  
 
We performed simulations with five organs: spleen, which has the lowest partition coefficient 
over blood (0.77), fat with the highest one (22), marrow, which has a low scaled flux value 
(0.0786 min-1), kidney with a high scaled flux value (3.9838 min-1) and liver, for which we 
studied the concentrations of both butadiene and its first metabolite.  
That choice of organs is also relevant relative to cancer risk of butadiene. Mutagenicity has 
been shown to occur for spleen and marrow of rodents (Preston, 2007). The same author 
reported butadiene-induced lymphomas so as lung and liver tumours in mice. 
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We ran 100 simulations at steady state. For spleen, kidney and liver, we reported the number 
of molecules at time 100 min, which is large compared to the time needed to reach 
equilibrium in the deterministic model for these organs. For marrow and fat, we reported this 
number at 500 min and 10000 min respectively due to a longer time to reach equilibrium. 
 
2.5. Coupling with cancer PD model 
To assess how dose-response curves are affected by stochasticity at the cellular level, we 
coupled the stochastic PBPK model described above to a linear model with a threshold for 
effect, which belongs to the family of the “hockey stick models” introduced into carcinogenic 
risk assessment by Cornfield (1977). For a given cell at a given time, the probability R of 
carcinogenesis is supposed to be proportional to max(N(t)-N0 , 0) where N(t) is the number of 
molecules of BD metabolites per cell at time t, N0 the threshold number of molecules to get an 
effect. We chose 1 as the threshold number of molecules per cell able to initiate liver 
carcinogenesis with a non-zero probability. This is the minimum reasonable number and it 
corresponds to approximately twice the general environment exposure in Japan (Higashino et 
al., 2007). This is just a choice for simulations. It is not based on particular knowledge about 
butadiene mechanisms of carcinogenicity. It is also worth noting that a purely linear dose-
response would not be affected by stochasticity. We adapted the proportionality factor 
between R and excess number of molecules so that the lifetime excess cancer risk level 
estimated for a continuous exposure to 1.7 µg/m3 BD is 10-5, as in the study by Higashino et 
al. (2007). 
We performed simulations for exposure concentrations from 0 to 1.7 µg/m3, with a step of 0.1 
µg/m3. For each concentration, we simulated, at steady state, the number of BD metabolites 




2.6. Stochastic simulations in time-varying conditions 
To study the system in a non steady-state situation (e. g. for a time-varying change in the 
exposure level) the exposure scenario simulated 9 hours a day to a BD concentration of 1.7 
µg/m3, followed by 15 hours a day to a BD concentration of 0.25 µg/m3. This is typically 
what a factory worker would be exposed to in Japan (Higashino et al., 2007).  For simplicity, 
holidays and week-ends were not accounted for.  
We added a component (accounting for a liver cell) in parallel to the liver in the PBPK model. 
It was not possible to implement time-varying deterministic concentrations in Jdesigner and 
Dizzy and use the same methods as in section 2.4. Therefore, we had to simulate with Dizzy 
simultaneously the dynamics in all organs and in a cell. However, we could not track all the 
molecules in the body even for an environmental exposure level of BD. Therefore, we had to 
adapt the PBPK model equations implemented in Jdesigner and Dizzy, so that simulated 
organ concentrations were approximately the deterministic ones and so that Gillespie 
algorithm was unchanged for the cell.  
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Consequently, if, in the PBPK model equations, we multiply the concentrations in all 











, fix at 0.01 the volume of the 
liver cell (both operations largely minimise stochasticity at organ level so as the contribution 
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of the liver cell to the whole system) and divide Forgan by 100, we have approximately the 
same kinetics at the organs level, without affecting the kinetics for Q_cell. The Gillespie 
algorithm is unchanged, because the reaction probability density function is unchanged. We 
indeed checked with Jdesigner and Dizzy that, once the model was adapted, the stochastic 
values of all organ concentrations differed by less than 5 % from their deterministic values 
during the simulations we performed. Using 10 and 0.1 instead of 100 and 0.01 in equation 
(13) would have led a large difference between deterministic values and stochastic ones. In 
contrast, using 1000 and 0.001 would have led to huge calculation times for Dizzy.  
We focused here only on EB in the liver. We performed simulations for 20 cells during the 15 
hours in the general environment and reported cell concentration. The concentrations at time 0 
(time at which the subject is just leaving industrial vicinity) are extracted from simulations 
with Jdesigner over 50 days. For the last 10 days, the values at time 0 only differed by 0.1 %, 




3.1. Stochastic simulations at steady state 
The mean number of molecules in a cell, the standard deviation and coefficient of variation 
per organ for exposure concentration 1.7 µg/m3 are presented in Table V. Stochastic mean 
values equal deterministic ones. 
The stochastic variability is mainly influenced by the partition coefficient (which determines 
the mean number of molecules at steady state). The fact that marrow and kidney have 
comparable standard deviations but very different mean number of molecules suggests that 
low blood flow to the cell also tends to decrease variability relative to the mean value. The 
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results obtained for metabolites in the liver are presented in Figure 2. There is a large 
variability of the number of metabolites in a liver cell (mean 2.91, standard deviation 1.71 
resulting in coefficient of variation of 0.588). Simulations for exposure concentration 0.25 
µg/m3 led to the same conclusions relative to organ characteristics and coefficient of variation 
(data not shown).  
 
3.2. Coupling with cancer model 
Figure 3 shows that accounting for stochasticity when coupling the PBPK model and cancer 
model increased the excess of risk even below the deterministic threshold of 0.6 µg/m3. The 
dose-response curve appears to have two distinct regimes: a “quadratic” looking region and a 
“linear” looking one, closed to the deterministic response. 
 
3.3. Stochastic simulations in time-varying conditions 
Figure 4 shows the results at dynamics steady state for metabolites in one liver cell for 15 
hours at exposure concentration 0.25 µg/m3 after 9 hours at exposure concentration 1.7 µg/m3. 
The metabolite mean concentration quickly reaches low levels (half of the initial value is 
reached after 13 minutes), at which stochasticity is high and kinetics is slow.  
The cancer model was used to assess the instantaneous excess risk of liver cancer during this 
period. There was no increased risk for times over 65 minutes, according to the deterministic 
approach. The sum over time of instantaneous excess risk values during this period outside 
the industrial vicinity corresponded to 12 minutes at steady state exposure at the high 
concentration, which is low compared to the 9 hours exposure. In contrast, when accounting 






The simple algorithms outlined in the works by Gillespie (Gillespie, 1977) permit the 
modeling of microscopic stochastic phenomena (Haseltine and Rawlings, 2002). Gillespie’s 
algorithms can be so expensive computationally that alternatives have been proposed to 
approximate exact simulations (Haseltine and Rawlings, 2002 ; Rathinam et al., 2003). For 
the present work, we chose to use the exact algorithm, for simulations could be performed in a 
reasonable amount of time with modern calculation stations, thanks to the progress that 
computer technology has still made in the past few years. 
Coupling our PBPK model to a model of excess risk of cancer affected dose response curve. It 
looks curvilinear, with a breakpoint dose lower than the theoretical one. Mutagenesis data 
from Elhajouji et al. (1997) showed experimentally comparable profile, with a slight increase 
in mutagenicity, then a highly significant steep increase for compounds likely to have a 
threshold for effects. We do not pretend to fully assess cancer risk associated to exposure to 
butadiene. Our study is a simulation study aiming at assessing whether or not stochasticity 
should be considered when assessing risk. Therefore, at least in the case of exposure to low 
doses of compounds having a threshold for carcinogenicity, stochasticity in kinetics should 
not be neglected.  
In a paper on dose-response and threshold-mediated mechanisms in mutagenesis, Lovell 
(2000) points that “absolute” threshold are difficult to estimate from toxicity data due to 
background noise as a consequence of stochasticity. The concept of absolute threshold may 
therefore make no physical sense at all. Lovell is in favour of “pragmatic” thresholds, 
constructed through dose–response models (in particular biology-based dose-response 
(BBDR) models) coupled with knowledge about what level of response is biologically 
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important, and what level is not. We believe that dose-response models construction should 
seriously consider stochasticity to get the best accurate representation of reality at low doses. 
BBDR models would permit to derive a deterministic approximate threshold, then 
stochasticity studies would permit to derive a realistic one based on stochastic simulations 
with BBDR models coupled with PBPK models. 
To our knowledge, this study is the first time that the dynamics of compounds at the cell level 
is studied in parallel to the dynamics at the body level. Coupling microscopic and 
macroscopic dynamics is a real challenge, because of the very large scale difference between 
numbers of molecules in cell and in organ. Here, we achieved the coupling of PBPK models 
with tools developed in the framework of systems biology through two different approaches. 
In case of steady state for organs, concentrations in PBPK compartments were fixed and exact 
dynamic equations for butadiene in the cell was derived. In case of time varying 
concentrations in the organs, we adapted the equations to get an approximate simulation of the 
dynamics at the cell level. We were then able to assess the influence of stochasticity relative 
to dose-response in toxicant risk assessment, with constant or time-varying exposure 
concentration. This coupling is not limited to toxicology. It can be immediately generalized to 
the study of stochastic concentration of many compounds in the cell, like for instance 
pharmaceuticals and hormones which may be effective at extremely low concentrations 
(Gurevich et al., 2003).  
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Table I. Values of the organ or tissue volumes (in L). These constants were calculated for a 
standard man of 1.76 m and 73 kg, using the organ weights given by the ICRP 2002 Pub 89 
(p.18(T 2.8)  p.19(T 2.9)). Density for the organs is supposed equal to 1 excepted for adipose 
tissues (density 0.9) and bones (density 2) 
Tissue / organ Symbol Value 
Adipose Vadip  18.8 
Adrenals Vadrenal  0.014 
Arterial blood Vart 1.40 
Venous blood  Vven  4.20 
Bone  Vbone  2.75 
Brain  Vbrain  1.45 
Breast  Vbreast  0.025 
Gut  Vgut  1.02 
Gut lumen Vgut_lumen 0.65 
Heart  Vheart  0.33 
Kidney  Vkidney  0.31 
Liver  Vliver  1.80 
Lung  Vlung  0.50 
Upper respiratory tract  Vurt  0.15 
Bone marrow  Vmarrow 3.65 
Muscles Vmuscle  29.0 
Others Vother  7.06 
Pancreas  Vpancreas  0.14 
Skin  Vskin  3.30 
Spleen  Vspleen  0.15 
Stomach  Vstomach  0.15 
Stomach lumen Vstom_lumen 0.25  
Testes Vtestes 0.056 




Table II. Blood flows for the various organs or tissues (Unit L/min). These have been 
computed using cardiac output, percent blood flows per tissue mass and organ weights given 
in ICRP 2002 Pub 89 [14] (Table 2.8  p18-19, Table 2.39 p28, Table 2.40  p29) or provided 
by William & Leggett [15]. 
Tissue or organ Symbol Value 
Adipose Fadip 0.564 
Adrenals Fadrenal 0.02 
Brain  Fbrain  0.78 
Breast  Fbreast  0.00 
Gut  Fgut 0.98 
Heart  Fheart  0.35 
Kidney  Fkidney  1.23 
Liver  Feport 0.45 
Lung  Ftotal 6.72 
Bone marrow  Fmarrow  0.29 
Muscles Fmuscle  1.11 
Others Fother 0.19 
Pancreas  Fpancreas 0.065 
Skin  Fskin 0.33 
Spleen  Fspleen  0.19 
Stomach  Fstomach 0.065 
Testes Ftestes 0.004 





Table III. BD and EB-specific parameters. These have been taken from Brochot et al. (2005) 
for BD parameters and Brochot et al. (2007) for EB parameter. 
Parameter Symbol Value Unit 
BD fat over blood partition coefficient  22 – 
BD lung over air partition coefficient Plung_over_air 0.653 – 
EB liver over blood partition coefficient Pliver_EB 0.59 – 
Metabolisation rate for BD into EB Kmet  0.3 L/min 
 
Table IV. Fat content for the various organs or tissues. These have been taken from Fiserova-
Bergerova (1983) and Van der Molen (1996). Default value is 0.049, which corresponds to 
“remaining organs” in Van der Molen (1996). 
Tissue or organ Value 
Adipose 0.859 
Adrenals        default 
Brain  0.11 
Breast         default 
Gut  0.065 
Heart  0.083 
Kidney  0.052 
Liver  0.049 
Lung  0.017 
Bone marrow  0.186 
Muscles 0.064 
Others        default 
Pancreas  0.105 
Skin  0.15 
Spleen  0.03 
Stomach         default 
Gonads        default 




Table V. Mean number of molecules in a cell, standard deviation and coefficient of variation 
per organ at steady state at time 100 (5000 for fat, 500 for marrow) for 100 simulations 
performed with Dizzy. Exposure concentration is 1.7 µg/m3.  
Organ Mean number of molecules in a cell Standard deviation Coefficient of variation 
Fat 379.3 10.0 0.026 
Marrow 82.3 4.49 0.0545 
Kidney 22.9 4.52 0.197 
Liver 15.2 3.2 0.211 






Figure 1. PBPK model for butadiene, as implemented in Jdesigner. 
Figure 2. Distribution of BD metabolites number per cell in a liver cell at steady state at time 
100 for 100 simulations performed with Dizzy. Exposure concentration is 1.7 µg/m3. 
Figure 3. Excess liver cancer risk in relation to exposure concentration. The deterministic 
probability is represented by the plain line. The points are the mean values obtained by 
stochastic simulations for 100 cells. 
Figure 4. Kinetics of butadiene metabolites in one liver cell for a man leaving industrial 
vicinity to general environment. Plain line is the deterministic model and points are stochastic 










Figure 2.  
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